Sleep-related traits and attention-deficit/hyperactivity disorder comorbidity: shared genetic risk factors, molecular mechanisms, and causal effects

Marina Xavier Carpena; Carolina Bonilla; Alicia Matijasevich; Thais Martins-Silva; Julia P. Genro; Mara Helena Hutz; Luis Augusto Rohde; Luciana Tovo-Rodrigues

doi:10.1101/2020.09.13.20193813

Abstract

Study Objectives To evaluate the level of shared genetic components between attention-deficit/hyperactivity disorder (ADHD) and sleep phenotype, common pathways between them and a possible causal relationship between traits.

Methods We used summary statistics of the largest genome-wide association studies available for ADHD and sleep-related phenotypes including insomnia, napping, daytime dozing, snoring, ease getting up, daytime sleepiness, sleep duration and chronotype. We estimated the genomic correlation between ADHD and sleep-related traits using cross-trait LD-score regression and investigated potential common mechanisms using gene-based cross-trait metanalyses and functional enrichment analyses. The causal effect between the sleep related traits and ADHD was estimated with two sample Mendelian randomization (TSMR), using the Inverse Variance Weighted method as the main estimator.

Results Positive genomic correlation between insomnia, daytime napping, daytime dozing, snoring, daytime sleepiness, short and long sleep duration, and ADHD were observed. Insomnia, sleep duration, daytime sleepiness, and snoring shared genes with ADHD, which were involved in neurobiological functions and regulatory signaling pathways. The TSMR approach supported a causal effect of insomnia, daytime napping, and short sleep duration on ADHD, and of ADHD on long sleep duration and chronotype.

Conclusion Our findings suggest that the comorbidity between sleep phenotypes and ADHD may be mediated by common genetic factors with an important role on neuronal signaling pathways. In addition, it may also exist a causal effect of sleep disturbances and short sleep duration on ADHD, reinforcing the role of these sleep phenotypes as predictors or early markers of ADHD.

Statement of Significance Our findings suggest that the comorbidity between sleep phenotypes and ADHD may be linked to common genetic factors with an important role on neuronal signaling pathways. They also show that a causal effect of sleep disturbances and short sleep duration on ADHD may exist, reinforcing the role of these sleep phenotypes as ADHD early markers, being able to predict the disorder. This study adds important information about the relationship between sleep, circadian rhythm, and ADHD since it raises new questions about the complexity of the phenomenon involving them and may also provide new treatment insights in this research field.

Competing Interest Statement

L.A.R. has been a member of the speakers bureau/advisory board and/or acted as a consultant for Medice, Novartis and Shire in the last three years. He receives authorship royalties from Oxford Press and ArtMed. He has also received travel awards from Shire for his participation in the 2018 APA meeting. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by him received unrestricted educational and research support from the following pharmaceutical companies in the last three years Janssen-Cilag, Novartis, and Shire. MXC, CB, AM, TMS, JPG, MHH and LTR have no biomedical financial interests or potential conflicts of interest.

Funding Statement

This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) Finance Code 001, and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, processo no. 427524/2018-0). MXC, AM and LTR were supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnolgico (CNPq). CB was supported by a Universidade de Sao Paulo Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior fellowship (processo no. 88887.160006/2017-00). TMS has received support by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES). Research projects conducted by MHH have been supported by CNPq. JPG has received support by the Research Support Foundation of Rio Grande do Sul FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

In this study, we have included the data (summary statistics) of the largest GWAS published to date. These studies had been approved by local ethics committees and had obtained the required informed consents (detailed in previously published papers)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes